Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modeling long-QT syndromes with iPS cells.

Journal of cardiovascular translational research - 1 Feb 2013

Sinnecker Daniel, Goedel Alexander, Dorn Tatjana, Dirschinger Ralf J, Moretti Alessandra, Laugwitz Karl-Ludwig

Abstract excerpt

The generation of induced pluripotent stem cells (iPSC) from human somatic cells bears the possibility to generate patient-specific stem cell lines which can serve as a theoretically unlimited source of somatic cells carrying the genotype of the patients. Different types of the long-QT syndrome have been studied by analyzing the phenotype of cardiomyocytes generated from patient-specific iPSC lines. Major aspects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Arrhythmia Agents
Share to Cells, Cultured

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Induced Pluripotent Stem Cells

Share to Ion Channels

Share to Long QT Syndrome

Share to Myocytes, Cardiac

Share to Risk Assessment

Share to Toxicity Tests

Source

Identifiers

PMID: 23076501
DOI: 10.1007/s12265-012-9416-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modeling long-QT syndromes with iPS cells.PMID 23076501Read ↗

Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges.Semantic proximity Read ↗

Induced Pluripotent Stem Cell–Derived CardiomyocytesSemantic proximity Read ↗

Induced Pluripotent Stem Cells in Congenital Long QT Syndrome: Research Progress and Clinical ApplicationsSemantic proximity Read ↗

Modeling genetic cardiac channelopathies using induced pluripotent stem cells - Status quo from an electrophysiological perspective.Semantic proximity Read ↗

Modelling the long QT syndrome with induced pluripotent stem cells.Semantic proximity Read ↗

Precision medicine for long QT syndrome: patient-specific iPSCs take the lead.Semantic proximity Read ↗

In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment.Semantic proximity Read ↗

Towards Precision Medicine With Human iPSCs for Cardiac ChannelopathiesSemantic proximity Read ↗

iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug DevelopmentSemantic proximity Read ↗

Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem CellsSemantic proximity Read ↗

Modeling Inherited Cardiac DisordersSemantic proximity Read ↗

Modeling Timothy syndrome with iPS cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.